Update on the medical management of stone disease

Current Opinion in Urology

Volumn 19, Issue 2, 2009, Pages 200-204

  Tracy, Chad R ^a   Pearle, Margaret S ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Citrus; Lemonade therapy; Metabolic syndrome; Probiotic; Stone risk

Indexed keywords

ALKALI; CALCIUM OXALATE; CALCIUM PHOSPHATE; CITRATE POTASSIUM; CITRIC ACID; FRUCTOSE; OXALIC ACID; POTASSIUM; PROBIOTIC AGENT;

BEVERAGE; CALCIUM OXALATE STONE; CLINICAL TRIAL; CRANBERRY JUICE; DIABETES MELLITUS; DIET THERAPY; EXTRACORPOREAL LITHOTRIPSY; GRAPEFRUIT JUICE; HEALTH CARE SYSTEM; HUMAN; HYPEROXALURIA; HYPERURICOSURIA; LACTIC ACID BACTERIUM; LEMON JUICE; MANDARIN; NEPHROLITHIASIS; NONHUMAN; OBESITY; ORANGE JUICE; OXALOBACTER FORMIGENES; PATIENT COMPLIANCE; PERCUTANEOUS NEPHROLITHOTOMY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; STONE FORMATION; TOMATO; URIC ACID STONE;

ANIMALS; CALCIUM OXALATE; CITRIC ACID; DIET; FRUCTOSE; HUMANS; NEPHROLITHIASIS; PROBIOTICS; RECURRENCE; URIC ACID;

EID: 61349106559     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e328323a81d     Document Type: Review

References (42)

1. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003; 63:1817-1823.
2. Ahlstrand C, Tiselius HG. Recurrences during a 10-year follow-up after first renal stone episode. Urol Res 1990; 18:397-399.
3. Ljunghall S, Danielson BG. A prospective study of renal stone recurrences. Br J Urol 1984; 56:122-124.
4. Trinchieri A, Ostini F, Nespoli R, et al. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 1999; 162:27-30.
5. Pearle MS, Roehrborn CG, Pak CY. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 1999; 13:679-685.
6. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996; 155:839-843.
7. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346:77-84.
8. Hamm LL, Hering-Smith KS. Pathophysiology of hypocitraturic nephrolithiasis. Endocrinol Metab Clin North Am 2002; 31:885-893; viii.
9. Pak CY. Medical management of urinary stone disease. Nephron Clin Pract 2004; 98:c49-c53.
10. Pearle MS, Lotan Y. Urinary lithiasis: etiology, epidemiology, and pathogenesis. In: Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology, 9th ed. Philadelphia, PA: Saunders; 2007.
11. Mattle D, Hess B. Preventive treatment of nephrolithiasis with alkali citrate: a critical review. Urol Res 2005; 33:73-79.
12. Pak CY, Fuller C, Sakhaee K, et al. Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 1985; 134:11-19.
13. Seltzer MA, Low RK, McDonald M, et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol 1996; 156:907-909.
14. Odvina CV. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol 2006; 1:1269-1274.
15. Koff SG, Raquette EL, Cullen J, et al. Comparison between lemonade and potassium citrate and impact on urine pH and 24-h urine parameters in patients with kidney stone formation. Urology 2007; 69:1013-1016.
16. Penniston KL, Steele TH, Nakada SY. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation. Urology 2007; 70:856-860.
17. Kang DE, Sur RL, Haleblian GE, et al. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol 2007; 177:1358-1362; discussion 1362, quiz 1591.
18. Haleblian GE, Leitao VA, Pierre SA, et al. Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis. J Endourol 2008; 22:1359-1366. This retrospective review of stone patients on long-term lemonade therapy is at odds with metabolic studies in that urinary parameters were positively influenced by lemonade therapy, although declining patient compliance with lemonade therapy over time resulted in unsustained improvements when compared with KCit.
19. Jenkins AD, Dousa TP, Smith LH. Transport of citrate across renal brush border membrane: effects of dietary acid and alkali loading. Am J Physiol 1985; 249:F590-F595.
20. Yilmaz E, Batislam E, Basar M, et al. Citrate levels in fresh tomato juice: a possible dietary alternative to traditional citrate supplementation in stone-forming patients. Urology 2008; 71:379-383; discussion 383-384. Provocative study suggesting a possible rale for tomato juice in the treatment of calcium oxalate nephrolithiasis.
21. Gross LS, Li L, Ford ES, Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004; 79:774-779.
22. Koh ET, Bourdeau JE, Tae WC. A magnesium-deficient high fructose diet augments bone-sparing action of exogenous oestrogen in ovariectomized rats. Magnes Res 1993; 6:333-342.
23. Koh ET, Reiser S, Fields M. Dietary fructose as compared to glucose and starch increases the calcium content of kidney of magnesium-deficient rats. J Nutr 1989; 119:1173-1178.
24. Milne DB, Nielsen FH. The interaction between dietary fructose and magnesium adversely affects macromineral homeostasis in men. J Am Coll Nutr 2000; 19:31-37.
25. Nguyen NU, Dumoulin G, Henriet MT, Regnard J. Increase in urinary calcium and oxalate after fructose infusion. Horm Metab Res 1995; 27: 155-158.
26. Taylor EN, Curhan GC. Fructose consumption and the risk of kidney stones. Kidney Int 2008; 73:207-212. Worrisome fructose gluttony affecting American societies may lead to a dramatic increase in symptomatic stone events in coming years.
27. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295:1549-1555.
28. National Institute of Diabetes and Digestive and Kidney Diseases. National diabetes statistics, 2007 fact sheet. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 2008.
29. Daudon M, Lacour B, Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 2005; 20:468-469.
30. Pak CY, Sakhaee K, Moe O, et al. Biochemical profile of stone-forming patients with diabetes mellitus. Urology 2003; 61:523-527.
31. Cameron MA, Maalouf NM, Adams-Huet B, et al. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 2006; 17:1422-1428.
32. Maalouf NM, Cameron MA, Moe OW, et al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007; 2:883-888. Alarming retrospective review shows that a propensity for development of type 2 diabetes confers a significant risk for the development of nephrolithiasis due to increased urinary acidity.
33. Procopiou M, Philippe J. The metabolic syndrome and type 2 diabetes: epidemiological figures and country specificities. Cerebrovasc Dis 2005; 20 (Suppl 1):2-8.
34. Ettinger B, Tang A, Citron JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986; 315:1386-1389.
35. Curhan GC, Taylor EN. 24-h uric acid excretion and the risk of kidney stones. Kidney Int 2008; 73:489-496.
36. Pais VM Jr, Holmes RP, Assimos DG. Effect of dietary control of urinary uric acid excretion in calcium oxalate stone formers and nonstone-forming controls. J Endourol 2007; 21:232-235. Dietary protein consumption is likely more important than endogenous uric acid production in patients with hyperuricosuria.
37. Kaufman DW, Kelly JP, Curhan GC, et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 2008; 19:1197-1203. Intestinal colonization by O. formigenes may decrease the risk of being a stone former.
38. Hoppe B, Beck B, Gatter N, et al. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 2006; 70:1305-1311.
39. Campieri C, Campieri M, Bertuzzi V, et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 2001; 60:1097-1105.
40. Goldfarb DS, Modersitzki F, Asplin JR. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol 2007; 2:745-749. This prospective, randomized, double-blind, placebo-controlled trial refutes a previous study, which showed that lactic acid bacteria could reduce urinary oxalate.
41. Soygur T, Akbay A, Kupeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 2002; 16:149-152.
42. Kang DE, Maloney MM, Haleblian GE, et al. Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy. J Urol 2007; 177:1785-1788; discussion 1788-1789. Targeted medical management of stone disease may not only limit stone recurrence after PNL but may also reduce the significance of residual fragments.